By: Alexander Sinclair, Stefan Kraemer, Christoph Reinhart, Jennifer Stehle, Simon Schuster, Tobias Herz, Hoor Al-Hasani, Pranav Hamde, Oliver Selinger, Jo
Abstract T-cell receptor mimic (TCRm) antibodies are an emerging class of tumor-targeting agents used in advanced immunotherapies such as bispecific T-cell engagers and CAR-T cells.



